JNJ Johnson & Johnson

NYSE
$265.58

Johnson & Johnson (JNJ) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with JNJ's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 5 sellers in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
10
29 transactions
Purchases
$257.7K
1,250 shares
Sales
$154.9M
630,943 shares
Net activity
-$154.6M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $154.9M 29 transactions · 630,943 shares

Largest single sale: $26.7M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 26, 2025 , by MORIKIS JOHN G .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Schmid Timothy 2 fills EVP, WW Chair, MedTech Sell 33,597 $274.74 $9.2M 25,447 −56.9% of holding
Taubert Jennifer L EVP, WWC. Innovative Medicine Sell 15,000 $263.36 $4.0M 194,451 −7.2% of holding
Duato Joaquin 2 fills CEO and Chairman of the Board Sell 123,291 $261.17 $32.2M 378,282 −24.6% of holding
Forminard Elizabeth 2 fills EVP, Chief Legal Officer Sell 15,918 $257.00 $4.1M 23,568 −40.3% of holding
Duato Joaquin 2 fills CEO and Chairman of the Board Sell 48,480 $258.15 $12.5M 282,490 −14.6% of holding
Broadhurst Vanessa EVP, Global Corp Affairs Sell 23,054 $251.27 $5.8M 23,003 −50.1% of holding
Wengel Kathryn E EVP, Chief TO and Risk Officer Sell 10,000 $241.15 $2.4M 114,288 −8% of holding
Decker Robert J VP Corporate Controller Sell 4,075 $247.87 $1.0M 23,682 −14.7% of holding
Schmid Timothy EVP, WW Chair, MedTech Sell 1,322 $245.66 $324.8K 25,447 −4.9% of holding
Schmid Timothy 2 fills EVP, WW Chair, MedTech Sell 22,623 $244.33 $5.5M 26,769 −45.8% of holding
Wolk Joseph J 4 fills Exec VP, CFO Sell 89,654 $242.80 $21.8M 38,961 −69.7% of holding
REED JOHN C 3 fills EVP, Innovative Medicine, R&D Sell 53,931 $243.00 $13.1M 12,941 −80.6% of holding
Swanson James D. EVP, CIO Sell 20,521 $242.70 $5.0M 25,698 −44.4% of holding
Broadhurst Vanessa EVP, Global Corp Affairs Sell 6,197 $243.39 $1.5M 23,003 −21.2% of holding
Swanson James D. 2 fills EVP, CIO Sell 41,559 $243.73 $10.1M 25,020 −62.4% of holding
Duato Joaquin 2 fills CEO and Chairman of the Board Sell 100,000 $221.23 $22.1M 79,634 −55.7% of holding
MORIKIS JOHN G Director Buy 1,250 $206.15 $257.7K 1,849
REED JOHN C EVP, Innovative Medicine, R&D Sell 21,721 $192.71 $4.2M 10,658 −67.1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.